blinatumomab

Related by string. Blinatumomab * * candidate blinatumomab MT# . antibody blinatumomab MT#/MEDI-# *

Related by context. Frequent words. (Click for all words.) 71 FOLOTYN 70 Marqibo 67 picoplatin 66 perifosine 66 INCB# [002] 66 ofatumumab 65 MGCD# [001] 65 HspE7 65 Phase 2b trial 64 XL# [003] 64 AP# [003] 64 Genasense 64 Phase Ib 63 Phase 2b clinical 63 satraplatin 63 IMGN# 62 Clolar 62 Phase 2b 62 Stimuvax 62 RG# [001] 62 Phase IIa trial 62 ZEVALIN 62 daclizumab 62 Phase 1b 61 Phase IIb clinical 61 tivozanib 61 Phase IIa clinical 61 ambrisentan 61 ASA# 61 CYT# 61 Tovaxin 60 Phase 2b study 60 pivotal Phase III 60 LymphoStat B 60 BiovaxID 60 Vidaza 60 myelofibrosis 60 PROVENGE 60 VELCADE 59 panitumumab 59 mipomersen 59 Phase IIb trial 59 AZD# 59 elesclomol 59 Phase III clinical 59 Prochymal 59 Phase 2a 59 T DM1 59 Phase III 59 investigational drug 58 Dacogen 58 Phase IIb 58 ADVEXIN 58 rituximab 58 investigational compound 58 relapsing remitting multiple sclerosis 58 linaclotide 58 nimotuzumab 58 Phase 2a clinical 58 hematologic malignancies 58 laquinimod 58 bapineuzumab 58 fidaxomicin 58 MDV# 58 dose escalation 58 clinical trial 57 AMR# 57 randomized Phase 57 Ceplene 57 IDX# 57 monotherapy 57 AEZS 57 hematological malignancies 57 Campath 57 telaprevir 57 FTY# 57 Phase III trials 57 ALKS 57 Phase III clinical trials 57 RDEA# 57 PLX# 57 natalizumab 57 sunitinib 57 bortezomib 56 Vectibix 56 pharmacodynamic 56 carfilzomib 56 LEVADEX 56 Locteron 56 Rituxan 56 ANA# 56 Oncophage 56 Denosumab 56 Kuvan 56 solid tumors 56 evaluable patients 56 SPRYCEL 56 pivotal Phase 56 dose escalation study 56 dasatinib 56 gefitinib

Back to home page